Span Divergent share news, announcements and annual reports
BSE: 524727Pharmaceuticals & BiotechnologySmall Cap
Span Divergent Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1995
Last close ₹23.94up ₹1.14 (5.00%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹22.80.
29 Oct: open ₹22.12, high ₹23.94, low ₹22.12
52-week range of traded prices to 29 Oct 2026
₹20.52Low, 8 Oct 2026₹51.49High, 1 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17 Cr4,116th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −24.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.73
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 208
Span Divergent orders, deals and press releases
12 filed, newest first.
Jul 2026
May 2026
Mar 2026
Feb 2026
Jan 2026
Aug 2024
13 Aug · Business
May 2021
Feb 2020
Nov 2015
20 Nov · Business
With reference to the earlier letter dated March 24, 2015, Span Diagnostics Ltd has now informed BSE that the Company has disinvested its entire 45% stake held in Joint Venture Company ....
Mar 2015
27 Mar · Business
Company has in principle agreed to disinvest its 45% stake held in Joint Venture Company namely Span Nihon Kohden Diagnostics Private Limited ....
Dec 2014
1 Dec · Business
Company has acquired additional stake in Span Diagnostics South Africa (Pty) Limited by purchase of 540 Equity Share of the Span Diagnostics ....